Samsung Bioepis

Incheon, South Korea CDMO Founded 2012 1000+ employees

South Korean biosimilar developer and CDMO providing biologics development, manufacturing, and analytical services with a portfolio of approved biosimilar products across global markets.

Services

ANALYTICAL

Method Development & Validation Stability Testing

MANUFACTURING

Formulation Development Fill-Finish Services Cell & Gene Therapy Manufacturing

Therapeutic Areas

Oncology Immunology Rare Disease

Contact

Locations

Incheon, South Korea
Delft, Netherlands

Certifications

GMP FDA Registered ISO 9001

Regulatory Experience

FDAEMAPMDA